Allison Wolf

Allison Wolf is an Executive Director in Global Regulatory Affairs CMC at Eli Lilly in Indianapolis, Indiana. She has been a regulatory scientist for over 22 years and has worked on small molecules, peptides, oligonucleotides, therapeutic proteins, monoclonal antibodies, and advanced therapies. Her experience spans clinical development, commercialization, and post marketing. Allison started her career as a medicinal chemist at Pharmacia and Upjohn in infectious disease discovery. In 2001, she moved into Regulatory CMC at Pharmacia/Pfizer and later joined Lilly as a regulatory scientist in 2003. In her current role, she is responsible for the development and implementation of CMC regulatory strategies for bioconjugates and advanced therapy medicinal products in clinical development through commercialization and licensure.